60541 Search Results


94
Addgene inc psbbi gfp hygromycin resistant vector

Psbbi Gfp Hygromycin Resistant Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60541/pmc08320529-162-0-4?v=Addgene+inc
Average 94 stars, based on 1 article reviews
psbbi gfp hygromycin resistant vector - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
BPS Bioscience fcγ chain adcc jurkat
DARA-mediated <t>ADCC</t> based on CD16 expressing NK cells. A BCBL-1, GTO, and TY-1 cells were incubated with various concentrations of DARA, and co-cultured with ADCC-indicating <t>Jurkat</t> cells (E:T ratio = 1:5) for 18 h. Luciferase activity was measured. B, C, D, E) CFSE-labeled BCBL-1 cells were treated with IgG1 or DARA, co-cultured with CD16 + NK (N6) or CD16- NK (KHYG-1) cell lines at different E:T ratio for 4 h, and analyzed for dead BCBL-1 (CFSE+Ghost Dye+) cells by flow cytometry. F Up-regulation of CD107a after DARA treatment was analyzed by flow cytometry. G Percentages of CD56+CD107a+ cells after stimulation with DARA (n = 3). Data are presented as mean values ± standard error (SE). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significant levels
Fcγ Chain Adcc Jurkat, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60541/pmc10991639-162-26-30?v=BPS+Bioscience
Average 93 stars, based on 1 article reviews
fcγ chain adcc jurkat - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
ATCC pichia stipitis cbs
DARA-mediated <t>ADCC</t> based on CD16 expressing NK cells. A BCBL-1, GTO, and TY-1 cells were incubated with various concentrations of DARA, and co-cultured with ADCC-indicating <t>Jurkat</t> cells (E:T ratio = 1:5) for 18 h. Luciferase activity was measured. B, C, D, E) CFSE-labeled BCBL-1 cells were treated with IgG1 or DARA, co-cultured with CD16 + NK (N6) or CD16- NK (KHYG-1) cell lines at different E:T ratio for 4 h, and analyzed for dead BCBL-1 (CFSE+Ghost Dye+) cells by flow cytometry. F Up-regulation of CD107a after DARA treatment was analyzed by flow cytometry. G Percentages of CD56+CD107a+ cells after stimulation with DARA (n = 3). Data are presented as mean values ± standard error (SE). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significant levels
Pichia Stipitis Cbs, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60541/10__1002_slash_jctb__1828-20-26-22?v=ATCC
Average 90 stars, based on 1 article reviews
pichia stipitis cbs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

91
Bio-Techne corporation human serpin a3/alpha 1-antichymotrypsin elisa kit (colorimetric)
DARA-mediated <t>ADCC</t> based on CD16 expressing NK cells. A BCBL-1, GTO, and TY-1 cells were incubated with various concentrations of DARA, and co-cultured with ADCC-indicating <t>Jurkat</t> cells (E:T ratio = 1:5) for 18 h. Luciferase activity was measured. B, C, D, E) CFSE-labeled BCBL-1 cells were treated with IgG1 or DARA, co-cultured with CD16 + NK (N6) or CD16- NK (KHYG-1) cell lines at different E:T ratio for 4 h, and analyzed for dead BCBL-1 (CFSE+Ghost Dye+) cells by flow cytometry. F Up-regulation of CD107a after DARA treatment was analyzed by flow cytometry. G Percentages of CD56+CD107a+ cells after stimulation with DARA (n = 3). Data are presented as mean values ± standard error (SE). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significant levels
Human Serpin A3/Alpha 1 Antichymotrypsin Elisa Kit (Colorimetric), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60541/bio-techne+corporation___nbp2-60541?v=Bio-Techne+corporation
Average 91 stars, based on 1 article reviews
human serpin a3/alpha 1-antichymotrypsin elisa kit (colorimetric) - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology exp cell res small interfering rna sirna dlg5 sirna
DARA-mediated <t>ADCC</t> based on CD16 expressing NK cells. A BCBL-1, GTO, and TY-1 cells were incubated with various concentrations of DARA, and co-cultured with ADCC-indicating <t>Jurkat</t> cells (E:T ratio = 1:5) for 18 h. Luciferase activity was measured. B, C, D, E) CFSE-labeled BCBL-1 cells were treated with IgG1 or DARA, co-cultured with CD16 + NK (N6) or CD16- NK (KHYG-1) cell lines at different E:T ratio for 4 h, and analyzed for dead BCBL-1 (CFSE+Ghost Dye+) cells by flow cytometry. F Up-regulation of CD107a after DARA treatment was analyzed by flow cytometry. G Percentages of CD56+CD107a+ cells after stimulation with DARA (n = 3). Data are presented as mean values ± standard error (SE). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significant levels
Exp Cell Res Small Interfering Rna Sirna Dlg5 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/60541/pm25478998-58-22-34?v=Santa+Cruz+Biotechnology
Average 85 stars, based on 1 article reviews
exp cell res small interfering rna sirna dlg5 sirna - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell

Article Title: Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

doi: 10.1016/j.cell.2021.05.021

Figure Lengend Snippet:

Article Snippet: pSBbi-GFP-hygromycin resistant vector , Addgene , 605414.

Techniques: Enzyme-linked Immunosorbent Assay, shRNA, Recombinant, Staining, SYBR Green Assay, Cell Isolation, Expressing, Clone Assay, Plasmid Preparation, Software

DARA-mediated ADCC based on CD16 expressing NK cells. A BCBL-1, GTO, and TY-1 cells were incubated with various concentrations of DARA, and co-cultured with ADCC-indicating Jurkat cells (E:T ratio = 1:5) for 18 h. Luciferase activity was measured. B, C, D, E) CFSE-labeled BCBL-1 cells were treated with IgG1 or DARA, co-cultured with CD16 + NK (N6) or CD16- NK (KHYG-1) cell lines at different E:T ratio for 4 h, and analyzed for dead BCBL-1 (CFSE+Ghost Dye+) cells by flow cytometry. F Up-regulation of CD107a after DARA treatment was analyzed by flow cytometry. G Percentages of CD56+CD107a+ cells after stimulation with DARA (n = 3). Data are presented as mean values ± standard error (SE). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significant levels

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma

doi: 10.1007/s00262-021-03054-8

Figure Lengend Snippet: DARA-mediated ADCC based on CD16 expressing NK cells. A BCBL-1, GTO, and TY-1 cells were incubated with various concentrations of DARA, and co-cultured with ADCC-indicating Jurkat cells (E:T ratio = 1:5) for 18 h. Luciferase activity was measured. B, C, D, E) CFSE-labeled BCBL-1 cells were treated with IgG1 or DARA, co-cultured with CD16 + NK (N6) or CD16- NK (KHYG-1) cell lines at different E:T ratio for 4 h, and analyzed for dead BCBL-1 (CFSE+Ghost Dye+) cells by flow cytometry. F Up-regulation of CD107a after DARA treatment was analyzed by flow cytometry. G Percentages of CD56+CD107a+ cells after stimulation with DARA (n = 3). Data are presented as mean values ± standard error (SE). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 significant levels

Article Snippet: Recombinant Jurkat T cells expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human FcγRIIIa, high affinity (V158) variant and Fcγ chain (ADCC-Jurkat) (#60,541, BPS Bioscience, San Diego, CA) were used to measure ADCC activity by reporter assay.

Techniques: Expressing, Incubation, Cell Culture, Luciferase, Activity Assay, Labeling, Flow Cytometry